KCNH2 and neoplasm: Furthermore, scDb-hERG1-β1-TRAIL showed a good pharmacokinetic and toxicologic profile in vivo, accumulated into tumor masses arising from TNBC cells and strongly reducing their growth by inducing apoptotic death.